Jupiter Asset Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Jupiter Asset Management’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-251,406	Closed	-$25M	–	260
2018 Q2	$25M	Sell	251,406 -12,299	-5%	-$1.06M	0.73%	30
2018 Q1	$21.4M	Buy	263,705 +47,839	+22%	+$3.87M	0.65%	34
2017 Q4	$17M	Buy	215,866 +52,916	+32%	+$4.4M	0.49%	51
2017 Q3	$15M	Buy	162,950 +119,281	+273%	+$11.5M	0.51%	49
2017 Q2	$4.94M	Hold	43,669	–	–	0.17%	133
2017 Q1	$4.37M	Sell	43,669 -1,000	-2%	-$107K	0.16%	161
2016 Q4	$4.8M	Hold	44,669	–	–	0.18%	144
2016 Q3	$5.56M	Sell	44,669 -1,040	-2%	-$123K	0.21%	118
2016 Q2	$4.86M	Hold	45,709	–	–	0.19%	148
2016 Q1	$5.23M	Sell	45,709 -3,608	-7%	-$423K	0.2%	130
2015 Q4	$7.03M	Sell	49,317 -1,456	-3%	-$168K	0.26%	89
2015 Q3	$4.56M	Hold	50,773	–	–	0.18%	135
2015 Q2	$5.85M	Buy	+50,773	New	+$5.33M	0.21%	126

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jupiter Asset Management's CBPO Position: Q3 2018 in Review

Jupiter Asset Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q3 2018, closing a stake of 251,406 shares — an estimated $25M sold.

Jupiter Asset Management first reported a position in CBPO in Q2 2015 and held it in 13 quarters. The position peaked at $25M in Q2 2018. 82 funds tracked by Wall St. Rank hold CBPO as of Q3 2018.

Jupiter Asset Management reported no remaining China Biologic Products Holdings, Inc. position as of Q3 2018 after selling out during the quarter.
Jupiter Asset Management sold 251,406 China Biologic Products Holdings, Inc. shares in Q3 2018, an estimated $25M.
Jupiter Asset Management first reported a position in China Biologic Products Holdings, Inc. in Q2 2015 and held it in 13 quarters.
Jupiter Asset Management's China Biologic Products Holdings, Inc. position peaked at $25M in Q2 2018.
82 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q3 2018.

Based on Jupiter Asset Management's 13F filing for Q3 2018, filed 9 Nov 2018.